Celecoxib as a Valuable Adjuvant in Cutaneous Melanoma Treated with Trametinib
2021 · International Journal of Molecular Sciences · 20 citations
https://doi.org/10.3390/ijms22094387
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
16
Papers
231
Citations
8
h-index
8
i10-index
Diana Tudor is an academic researcher from Iuliu Hațieganu University of Medicine and Pharmacy. The author has contributed to research in topics: Iron Metabolism and Disorders & Melanoma and MAPK Pathways & Erythropoietin and Anemia Treatment. The author has an h-index of 8, co-authored 14 publications.
ORCID: 0000-0002-5997-8586Click to start Chat